company background image
A246

T&R Biofab KOSDAQ:A246710 Stock Report

Last Price

₩20.10k

Market Cap

₩417.9b

7D

2.0%

1Y

5.9%

Updated

17 May, 2022

Data

Company Financials
A246710 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

A246710 Stock Overview

T&R Biofab Co., Ltd. engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry.

T&R Biofab Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for T&R Biofab
Historical stock prices
Current Share Price₩20,100.00
52 Week High₩45,500.00
52 Week Low₩13,950.00
Beta0.73
1 Month Change-23.28%
3 Month Change10.74%
1 Year Change5.93%
3 Year Change97.06%
5 Year Changen/a
Change since IPO221.60%

Recent News & Updates

Mar 09
Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?

Do Insiders Own Lots Of Shares In T&R Biofab Co., Ltd. (KOSDAQ:246710)?

A look at the shareholders of T&R Biofab Co., Ltd. ( KOSDAQ:246710 ) can tell us which group is most powerful. Large...

Jan 12
Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?

Can You Imagine How T&R Biofab's (KOSDAQ:246710) Shareholders Feel About The 65% Share Price Increase?

T&R Biofab Co., Ltd. ( KOSDAQ:246710 ) shareholders might be concerned after seeing the share price drop 12% in the...

Nov 18
Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?

Do Institutions Own T&R Biofab Co., Ltd. (KOSDAQ:246710) Shares?

The big shareholder groups in T&R Biofab Co., Ltd. (KOSDAQ:246710) have power over the company. Generally speaking, as...

Shareholder Returns

A246710KR Medical EquipmentKR Market
7D2.0%1.3%0.9%
1Y5.9%-5.8%-15.0%

Return vs Industry: A246710 exceeded the KR Medical Equipment industry which returned -6.2% over the past year.

Return vs Market: A246710 exceeded the KR Market which returned -15.8% over the past year.

Price Volatility

Is A246710's price volatile compared to industry and market?
A246710 volatility
A246710 Average Weekly Movement10.2%
Medical Equipment Industry Average Movement5.8%
Market Average Movement5.6%
10% most volatile stocks in KR Market10.3%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A246710 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: A246710's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2013n/aWonsoo Yunhttps://www.tnrbiofab.com

T&R Biofab Co., Ltd. engages in the research and development of medical devices for transplantation and tissue regeneration in the areas of orthopedics, plastic surgery, and dentistry. It offers craniomaxillofacial meshes, dental meshes, and patient specific implants; and bioinks for 3D bioprinting and cell culture, stem cell research and delivery, and coating of scaffold and cultural dishes. The company was founded in 2013 and is based in Siheung-si, South Korea.

T&R Biofab Fundamentals Summary

How do T&R Biofab's earnings and revenue compare to its market cap?
A246710 fundamental statistics
Market Cap₩417.92b
Earnings (TTM)-₩11.08b
Revenue (TTM)₩3.23b

129.2x

P/S Ratio

-37.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A246710 income statement (TTM)
Revenue₩3.23b
Cost of Revenue₩3.47b
Gross Profit-₩234.30m
Other Expenses₩10.85b
Earnings-₩11.08b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-533.05
Gross Margin-7.24%
Net Profit Margin-342.64%
Debt/Equity Ratio69.9%

How did A246710 perform over the long term?

See historical performance and comparison

Valuation

Is T&R Biofab undervalued compared to its fair value and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


10.05x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate A246710's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate A246710's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: A246710 is unprofitable, so we can't compare its PE Ratio to the KR Medical Equipment industry average.

PE vs Market: A246710 is unprofitable, so we can't compare its PE Ratio to the KR market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A246710's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A246710 is overvalued based on its PB Ratio (10x) compared to the KR Medical Equipment industry average (2.4x).


Future Growth

How is T&R Biofab forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


4.6%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as T&R Biofab has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has T&R Biofab performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-20.6%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A246710 is currently unprofitable.

Growing Profit Margin: A246710 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: A246710 is unprofitable, and losses have increased over the past 5 years at a rate of 20.6% per year.

Accelerating Growth: Unable to compare A246710's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A246710 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (30.5%).


Return on Equity

High ROE: A246710 has a negative Return on Equity (-26.58%), as it is currently unprofitable.


Financial Health

How is T&R Biofab's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: A246710's short term assets (₩63.7B) exceed its short term liabilities (₩1.7B).

Long Term Liabilities: A246710's short term assets (₩63.7B) exceed its long term liabilities (₩38.9B).


Debt to Equity History and Analysis

Debt Level: A246710 has more cash than its total debt.

Reducing Debt: A246710's debt to equity ratio has increased from 2.3% to 69.9% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: A246710 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: A246710 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 22.6% each year


Dividend

What is T&R Biofab current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A246710's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A246710's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A246710's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A246710's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A246710 has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Wonsoo Yun

no data

Tenure

Wonsoo Yun is Chief Executive Officer and President of T&R Biofab Co., Ltd.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.7%.


Top Shareholders

Company Information

T&R Biofab Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: T&R Biofab Co., Ltd.
  • Ticker: A246710
  • Exchange: KOSDAQ
  • Founded: 2013
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: ₩417.918b
  • Shares outstanding: 20.79m
  • Website: https://www.tnrbiofab.com

Location

  • T&R Biofab Co., Ltd.
  • #542, Smart-Hub Ind-Uni Convergence Ctr
  • 237 Sangidaehak-ro
  • Siheung-Si
  • Gyeonggi-do
  • 15073
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/17 00:00
End of Day Share Price2022/05/17 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.